FMR »

Context Therapeutics shares owned by FMR

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by FMR from 13F filings

Historical chart of FMR investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by FMR

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4k 2.6k 0.55

More positions owned by FMR

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Micron Technology (MU)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ge Vernova (GEV)
Exxon Mobil Corporation (XOM)
Ge Aerospace Com New (GE)

View all positions for FMR

Top funds holding Context Therapeutics

Nextech Invest
Deep Track Capital
Soleus Capital Management
BlackRock
Avidity Partners Management
Franklin Resources
Vanguard Capital Management
Octagon Capital Advisors
Blue Owl Capital Holdings
TCG Crossover Management
Geode Capital Management
MPM Oncology Impact Management
Renaissance Technologies
Acadian Asset Management
ADAR1 Capital Management

View all funds holding Context Therapeutics